42
Participants
Start Date
June 30, 2011
Primary Completion Date
April 30, 2013
Study Completion Date
April 30, 2013
docetaxel + cyclophosphamide + pegfilgrastim
docetaxel 75 mg/m2 + cyclophosphamide 600 mg/m2 IV every 2 weeks x 4 cycles plus pegfilgrastim 6mg sq 24-48 hours post day 1 of each cycle
University of Wisconsin Carbone Cancer Center, Madison
Collaborators (1)
Amgen
INDUSTRY
University of Wisconsin, Madison
OTHER